News Releases

Join Drs. Larry Corey and John Mascola for a discussion on COVID-19 vaccines

Hear from two global experts about how existing partnerships, networks and infrastructure can be used to develop, test and distribute vaccines safely and effectively, in record time

Dr. Larry Corey and Dr. John Mascola— who are leading the charge to develop COVID-19 vaccines — join Fred Hutch President and Director Dr. Tom Lynch  to discuss the challenges and opportunities in accelerating development and distribution of COVID-19 vaccines for our integrated world. The presentation is part of the Fred Hutch’s Science Says series.

Drs. Corey and Mascola recently co-authored an article in Science with Dr. Anthony Fauci and Dr. Francis Collins calling for collaboration between academia, government and industry to develop potential vaccines for the SARS-CoV-2 coronavirus.

Please RSVP by June 4, and submit questions for our experts. After you register, you will receive instructions via email for joining the event by computer or phone.

Who:            Dr. Tom Lynch, President and Director, Fred Hutch

                    Dr. Larry Corey, Professor, Vaccine and Infectious Disease Division and Past President and Director,  Fred Hutch

                    Dr. John Mascola, Director, Vaccine Research Center, National Institute of Allergy and Infectious  Diseases

What:         Science Says: Expert Series discussion on COVID-19 vaccines with Drs. Larry Corey and John Mascola

When:         Friday, June 5, 2020 11 a.m. PST / 2 p.m. EST              

Where:       Virtual – Please RSVP here

                                                                           # # #

Media contact:

Claire Hudson  crhudson@fredhutch.org

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.